[1]
van Herwerden, E.F.; Sussmuth, R.D. Sources for leads: Natural products and libraries. Handb. Exp. Pharmacol., 2016, 232, 91-123.
[2]
Rishton, G.M. Reactive compounds and in vitro false positives in HTS. Drug Discov. Today, 1997, 2(9), 382-384.
[3]
Hugenholtz, P.; Goebel, B.M.; Pace, N.R. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J. Bacteriol., 1998, 180(18), 4765-4774.
[4]
Verpoorte, R. Exploration of nature’s chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov. Today, 1998, 3(5), 232-238.
[5]
Krawczyk, B.; Voller, G.H.; Voller, J.; Ensle, P.; Sussmuth, R.D. Curvopeptin: A new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase. ChemBioChem, 2012, 13(14), 2065-2071.
[6]
Cociancich, S.; Pesic, A.; Petras, D.; Uhlmann, S.; Kretz, J.; Schubert, V.; Vieweg, L.; Duplan, S.; Marguerettaz, M.; Noell, J.; Pieretti, I.; Hugelland, M.; Kemper, S.; Mainz, A.; Rott, P.; Royer, M.; Sussmuth, R.D. The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine. Nat. Chem. Biol., 2015, 11(3), 195-197.
[7]
Ling, L.L.; Schneider, T.; Peoples, A.J.; Spoering, A.L.; Engels, I.; Conlon, B.P.; Mueller, A.; Schaberle, T.F.; Hughes, D.E.; Epstein, S.; Jones, M.; Lazarides, L.; Steadman, V.A.; Cohen, D.R.; Felix, C.R.; Fetterman, K.A.; Millett, W.P.; Nitti, A.G.; Zullo, A.M.; Chen, C.; Lewis, K. A new antibiotic kills pathogens without detectable resistance. Nature, 2015, 517(7535), 455-459.
[8]
Hornung, A.; Bertazzo, M.; Dziarnowski, A.; Schneider, K.; Welzel, K.; Wohlert, S.E.; Holzenkampfer, M.; Nicholson, G.J.; Bechthold, A.; Sussmuth, R.D.; Vente, A.; Pelzer, S. A genomic screening approach to the structure-guided identification of drug candidates from natural sources. ChemBioChem, 2007, 8(7), 757-766.
[9]
Bachmann, B.O.; Van Lanen, S.G.; Baltz, R.H. Microbial genome mining for accelerated natural products discovery: Is a renaissance in the making? J. Ind. Microbiol. Biotechnol., 2014, 41(2), 175-184.
[10]
Molohon, K.J.; Melby, J.O.; Lee, J.; Evans, B.S.; Dunbar, K.L.; Bumpus, S.B.; Kelleher, N.L.; Mitchell, D.A. Structure determination and interception of biosynthetic intermediates for the plantazolicin class of highly discriminating antibiotics. ACS Chem. Biol., 2011, 6(12), 1307-1313.
[11]
Voller, G.H.; Krawczyk, J.M.; Pesic, A.; Krawczyk, B.; Nachtigall, J.; Sussmuth, R.D. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing. ChemBioChem, 2012, 13(8), 1174-1183.
[12]
Caetano, T.; Krawczyk, J.M.; Mosker, E.; Sussmuth, R.D.; Mendo, S. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem. Biol., 2011, 18(1), 90-100.
[13]
Oldach, F.; Al Toma, R.; Kuthning, A.; Caetano, T.; Mendo, S.; Budisa, N.; Sussmuth, R.D. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Angew. Chem. Int. Ed. Engl., 2012, 51(2), 415-418.
[14]
Sepkowitz, K.A. AIDS--the first 20 years. N. Engl. J. Med., 2001, 344(23), 1764-1772.
[15]
Fettig, J.; Swaminathan, M.; Murrill, C.S.; Kaplan, J.E. Global epidemiology of HIV. Infect. Dis. Clin. North Am., 2014, 28(3), 323-337.
[16]
Volberding, P.A.; Deeks, S.G. Antiretroviral therapy and management of HIV infection. Lancet, 2010, 376(9734), 49-62.
[17]
Moore, R.D.; Chaisson, R.E. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS, 1999, 13(14), 1933-1942.
[18]
Deeks, S.G.; Lewin, S.R.; Havlir, D.V. The end of AIDS: HIV infection as a chronic disease. Lancet, 2013, 382(9903), 1525-1533.
[19]
Ng, T.B.; Cheung, R.C.; Wong, J.H.; Chan, W.Y. Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes. Appl. Microbiol. Biotechnol., 2015, 99(24), 10399-10414.
[20]
Killian, M.S.; Levy, J.A. HIV/AIDS: 30 years of progress and future challenges. Eur. J. Immunol., 2011, 41(12), 3401-3411.
[21]
Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, 136(5), E359-E386.
[22]
Hosseini, A.; Ghorbani, A. Cancer therapy with phytochemicals: Evidence from clinical studies. Avicenna J. Phytomed., 2015, 5(2), 84-97.
[23]
Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nano, 2007, 2(12), 751-760.
[24]
Kumari, P.; Ghosh, B.; Biswas, S. Nanocarriers for cancer-targeted drug delivery. J. Drug Target., 2016, 24(3), 179-191.
[25]
Ling, C.Q.; Yue, X.Q.; Ling, C. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J. Integr. Med., 2014, 12(4), 331-335.
[26]
Zhao, C.Q.; Zhou, Y.; Ping, J.; Xu, L.M. Traditional Chinese medicine for treatment of liver diseases: Progress, challenges and opportunities. J. Integr. Med., 2014, 12(5), 401-408.
[27]
Wang, J.; Lin, F.; Guo, L.L.; Xiong, X.J.; Fan, X. Cardiovascular disease, mitochondria, and Traditional Chinese Medicine. Evid. Based Complement. Alternat. Med., 2015, 2015, 143145.
[28]
Yao, Z.; Zhang, L.; Ji, G. Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes. J. Integr. Med., 2014, 12(3), 135-146.
[29]
Seto, S.W.; Yang, G.Y.; Kiat, H.; Bensoussan, A.; Kwan, Y.W.; Chang, D. Diabetes mellitus, cognitive impairment, and Traditional Chinese Medicine. Int. J. Endocrinol., 2015, 2015, 810439.
[30]
Wang, S.; Tang, Q.; Qian, W.; Fan, Y. Meta-analysis of clinical trials on traditional Chinese herbal medicine for treatment of persistent allergic rhinitis. Allergy, 2012, 67(5), 583-592.
[31]
Kennedy, D.O.; Haskell, C.F.; Mauri, P.L.; Scholey, A.B. Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine. Hum. Psychopharmacol., 2007, 22(4), 199-210.
[32]
Ling, C.Q.; Wang, L.N.; Wang, Y.; Zhang, Y.H.; Yin, Z.F.; Wang, M.; Ling, C. The roles of traditional Chinese medicine in gene therapy. J. Integr. Med., 2014, 12(2), 67-75.
[33]
Wang, S.; Hu, Y.; Tan, W.; Wu, X.; Chen, R.; Cao, J.; Chen, M.; Wang, Y. Compatibility art of traditional Chinese medicine: From the perspective of herb pairs. J. Ethnopharmacol., 2012, 143(2), 412-423.
[34]
Ulrich-Merzenich, G.; Panek, D.; Zeitler, H.; Vetter, H.; Wagner, H. Drug development from natural products: Exploiting synergistic effects. Indian J. Exp. Biol., 2010, 48(3), 208-219.
[35]
Gurib-Fakim, A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol. Aspects Med., 2006, 27(1), 1-93.
[36]
Fowler, M.W. Plants, medicines and man. J. Sci. Food Agric., 2006, 86(12), 1797-1804.
[37]
Balunas, M.J.; Kinghorn, A.D. Drug discovery from medicinal plants. Life Sci., 2005, 78(5), 431-441.
[38]
Lam, S.K.; Ng, T.B. Acafusin, a dimeric antifungal protein from Acacia confusa seeds. Protein Pept. Lett., 2010, 17(7), 817-822.
[39]
Lam, S.K.; Ng, T.B. Acaconin, a chitinase-like antifungal protein with cytotoxic and anti-HIV-1 reverse transcriptase activities from Acacia confusa seeds. Acta Biochim. Pol., 2010, 57(3), 299-304.
[40]
Lopes, J.L.; Valadares, N.F.; Moraes, D.I.; Rosa, J.C.; Araujo, H.S.; Beltramini, L.M. Physico-chemical and antifungal properties of protease inhibitors from Acacia plumosa. Phytochemistry, 2009, 70(7), 871-879.
[41]
Zhao, M.; Ma, Y.; Pan, Y.H.; Zhang, C.H.; Yuan, W.X. A hevein-like protein and a class I chitinase with antifungal activity from leaves of the paper mulberry. Biomed. Chromatogr., 2011, 25(8), 908-912.
[42]
Liu, W.Y.; Chiou, S.J.; Ko, C.Y.; Lin, T.Y. Functional characterization of three ethylene response factor genes from Bupleurum kaoi indicates that BkERFs mediate resistance to Botrytis cinerea. J. Plant Physiol., 2011, 168(4), 375-381.
[43]
Lam, S.K.; Ng, T.B. A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds. Phytomedicine, 2009, 16(5), 444-450.
[44]
Huang, R.H.; Xiang, Y.; Liu, X.Z.; Zhang, Y.; Hu, Z.; Wang, D.C. Two novel antifungal peptides distinct with a five-disulfide motif from the bark of Eucommia ulmoides Oliv. FEBS Lett., 2002, 521(1-3), 87-90.
[45]
Huang, X.; Xie, W.; Gong, Z. Characteristics and antifungal activity of a chitin binding protein from Ginkgo biloba. FEBS Lett., 2000, 478(1-2), 123-126.
[46]
Wang, H.; Ng, T.B. Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein. Biochem. Biophys. Res. Commun., 2000, 279(2), 407-411.
[47]
Qin, X.; Shao, C.; Hou, P.; Gao, J.; Lei, N.; Jiang, L.; Ye, S.; Gou, C.; Luo, S.; Zheng, X.; Gu, X.; Zhu, X.; Xu, Y.; Chen, F. Different functions and expression profiles of curcin and curcin-L in Jatropha curcas L. Z. Naturforsch. C, 2010, 65(5-6), 355-362.
[48]
Yang, X.; Wang, X.; Li, X.; Zhang, B.; Xiao, Y.; Li, D.; Xie, C.; Pei, Y. Characterization and expression of an nsLTPs-like antimicrobial protein gene from motherwort (Leonurus japonicus). Plant Cell Rep., 2008, 27(4), 759-766.
[49]
Wang, H.; Ng, T.B. Isolation of lilin, a novel arginine- and glutamate-rich protein with potent antifungal and mitogenic activities from lily bulbs. Life Sci., 2002, 70(9), 1075-1084.
[50]
Wang, B.; Shi, X.; Guo, C.; Ye, X.; Wang, Z.; Rao, P. Isolation and purification of ribosome-inactivating proteins from bitter melon seeds by ion exchange chromatographic columns in series. Se Pu, 2004, 22(5), 543-546.
[51]
Wang, S.; Zhang, Y.; Liu, H.; He, Y.; Yan, J.; Wu, Z.; Ding, Y. Molecular cloning and functional analysis of a recombinant ribosome-inactivating protein (alpha-momorcharin) from Momordica charantia. Appl. Microbiol. Biotechnol., 2012, 96(4), 939-950.
[52]
Qian, Q.; Huang, L.; Yi, R.; Wang, S.; Ding, Y. Enhanced resistance to blast fungus in rice (Oryza sativa L.) by expressing the ribosome-inactivating protein alpha-momorcharin. Plant Sci., 2014, 217-218, 1-7.
[53]
Pan, W.L.; Wong, J.H.; Fang, E.F.; Chan, Y.S.; Ng, T.B.; Cheung, R.C. Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. Biochem. Pharmacol., 2014, 89(3), 329-339.
[54]
Zhang, B.; Xie, C.; Wei, Y.; Li, J.; Yang, X. Purification and characterisation of an antifungal protein, MCha-Pr, from the intercellular fluid of bitter gourd (Momordica charantia) leaves. Protein Expr. Purif., 2015, 107, 43-49.
[55]
Pinto, C.E.; Farias, D.F.; Carvalho, A.F.; Oliveira, J.T.; Pereira, M.L.; Grangeiro, T.B.; Freire, J.E.; Viana, D.A.; Vasconcelos, I.M. Food safety assessment of an antifungal protein from Moringa oleifera seeds in an agricultural biotechnology perspective. Food Chem. Toxicol., 2015, 83, 1-9.
[56]
Gifoni, J.M.; Oliveira, J.T.; Oliveira, H.D.; Batista, A.B.; Pereira, M.L.; Gomes, A.S.; Oliveira, H.P.; Grangeiro, T.B.; Vasconcelos, I.M. A novel chitin-binding protein from Moringa oleifera seed with potential for plant disease control. Biopolymers, 2012, 98(4), 406-415.
[57]
Batista, A.B.; Oliveira, J.T.; Gifoni, J.M.; Pereira, M.L.; Almeida, M.G.; Gomes, V.M.; Da Cunha, M.; Ribeiro, S.F.; Dias, G.B.; Beltramini, L.M.; Lopes, J.L.; Grangeiro, T.B.; Vasconcelos, I.M. New insights into the structure and mode of action of Mo-CBP3, an antifungal chitin-binding protein of Moringa oleifera seeds. PLoS One, 2014, 9(10), e111427.
[58]
Freire, J.E.; Vasconcelos, I.M.; Moreno, F.B.; Batista, A.B.; Lobo, M.D.; Pereira, M.L.; Lima, J.P.; Almeida, R.V.; Sousa, A.J.; Monteiro-Moreira, A.C.; Oliveira, J.T.; Grangeiro, T.B. Mo-CBP3, an antifungal chitin-binding protein from Moringa oleifera seeds, is a member of the 2S albumin family. PLoS One, 2015, 10(3), e0119871.
[59]
He, X.M.; Ji, N.; Xiang, X.C.; Luo, P.; Bao, J.K. Purification, characterization, and molecular cloning of a novel antifungal lectin from the roots of Ophioglossum pedunculosum. Appl. Biochem. Biotechnol., 2011, 165(7-8), 1458-1472.
[60]
Da-Hui, L.; Gui-Liang, J.; Ying-Tao, Z.; Tie-Min, A. Bacterial expression of a Trichosanthes kirilowii defensin (TDEF1) and its antifungal activity on Fusarium oxysporum. Appl. Microbiol. Biotechnol., 2007, 74(1), 146-151.
[61]
Xu, L.; Wang, Y.; Wang, L.; Gao, Y.; An, C. TYchi, a novel chitinase with RNA N-glycosidase and anti-tumor activities. Front. Biosci., 2008, 13, 3127-3135.
[62]
Hu, P.; An, C.; Li, Y.; Chen, Z. Prokaryotic expressed trichosanthin and other two proteins have anti-fungal activity in vitro. Wei Sheng Wu Xue Bao, 1999, 39(3), 234-240.
[63]
Fang, E.F.; Zhang, C.Z.; Zhang, L.; Wong, J.H.; Chan, Y.S.; Pan, W.L.; Dan, X.L.; Yin, C.M.; Cho, C.H.; Ng, T.B. Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS One, 2012, 7(9), e41592.
[64]
Girish, K.S.; Machiah, K.D.; Ushanandini, S.; Harish Kumar, K.; Nagaraju, S.; Govindappa, M.; Vedavathi, M.; Kemparaju, K. Antimicrobial properties of a non-toxic glycoprotein (WSG) from Withania somnifera (Ashwagandha). J. Basic Microbiol., 2006, 46(5), 365-374.
[65]
Ghosh Dasgupta, M.; George, B.S.; Bhatia, A.; Sidhu, O.P. Characterization of Withania somnifera leaf transcriptome and expression analysis of pathogenesis-related genes during salicylic acid signaling. PLoS One, 2014, 9(4), e94803.
[66]
Ng, T.B.; Au, T.K.; Lam, T.L.; Ye, X.Y.; Wan, D.C. Inhibitory effects of antifungal proteins on human immunodeficiency virus type 1 reverse transcriptase, protease and integrase. Life Sci., 2002, 70(8), 927-935.
[67]
Wang, H.X.; Ng, T.B. Purification of allivin, a novel antifungal protein from bulbs of the round-cloved garlic. Life Sci., 2001, 70(3), 357-365.
[68]
Seo, H.H.; Park, S.; Oh, B.J.; Back, K.; Han, O.; Kim, J.I.; Kim, Y.S. Overexpression of a defensin enhances resistance to a fruit-specific anthracnose fungus in pepper. PLoS One, 2014, 9(5), e97936.
[69]
Ye, X.Y.; Ng, T.B. Delandin, a chitinase-like protein with antifungal, HIV-1 reverse transcriptase inhibitory and mitogenic activities from the rice bean Delandia umbellata. Protein Expr. Purif., 2002, 24(3), 524-529.
[70]
Ye, X.Y.; Wang, H.X.; Ng, T.B. Dolichin, a new chitinase-like antifungal protein isolated from field beans (Dolichos lablab). Biochem. Biophys. Res. Commun., 2000, 269(1), 155-159.
[71]
Ngai, P.H.; Ng, T.B. Purification of glysojanin, an antifungal protein, from the black soybean Glycine soja. Biochem. Cell Biol., 2003, 81(6), 387-394.
[72]
Wang, S.; Wu, J.; Rao, P.; Ng, T.B.; Ye, X. A chitinase with antifungal activity from the mung bean. Protein Expr. Purif., 2005, 40(2), 230-236.
[73]
Wang, S.Y.; Wu, J.H.; Ng, T.B.; Ye, X.Y.; Rao, P.F. A non-specific lipid transfer protein with antifungal and antibacterial activities from the mung bean. Peptides, 2004, 25(8), 1235-1242.
[74]
Wang, S.Y.; Zhou, K.J.; Ye, X.Y.; Xu, Z.B.; Wu, J.H.; Rao, P.F. Crystallization and preliminary X-ray crystallographic analysis of a non-specific lipid-transfer protein with antipathogenic activity from Phaseolus mungo Acta Crystallogr. D. Biol. Crystallogr., 2004. 60(Pt 12 Pt 2), 2391-2393
[75]
Ye, X.Y.; Ng, T.B. Mungin, a novel cyclophilin-like antifungal protein from the mung bean. Biochem. Biophys. Res. Commun., 2000, 273(3), 1111-1115.
[76]
Li, M.; Wang, H.; Ng, T.B. An antifungal peptide with antiproliferative activity toward tumor cells from red kidney beans. Protein Pept. Lett., 2011, 18(6), 594-600.
[77]
Wong, J.H.; Ip, D.C.; Ng, T.B.; Chan, Y.S.; Fang, F.; Pan, W.L. A defensin-like peptide from Phaseolus vulgaris cv. ‘King Pole Bean’. Food Chem., 2012, 135(2), 408-414.
[78]
Ye, X.Y.; Ng, T.B. Purification of angularin, a novel antifungal peptide from adzuki beans. J. Pept. Sci., 2002, 8(3), 101-106.
[79]
Wang, H.; Ng, T.B. An antifungal protein from ginger rhizomes. Biochem. Biophys. Res. Commun., 2005, 336(1), 100-104.
[80]
Hawksworth, D.L. Mushrooms: The extent of the unexplored potential. Int. J. Med. Mushrooms, 2001, 3, 333-337.
[81]
Chang, S.T.; Buswell, J.A. Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) - a mushrooming medicinal mushroom. Int. J. Med. Mushrooms, 1999, 1, 139-146.
[82]
Ikekawa, T. Beneficial effects of edible and medicinal mushrooms on health care. Int. J. Med. Mushrooms, 2001, 3, 291-298.
[83]
Gao, Y.; Zhou, S. The immunomodulating effects of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) (Aphyllophoromycetideae). Int. J. Med. Mushrooms, 2002, 4, 1-11.
[84]
Ngai, P.H.; Zhao, Z.; Ng, T.B. Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea. Peptides, 2005, 26(2), 191-196.
[85]
Park, B.T.; Na, K.H.; Jung, E.C.; Park, J.W.; Kim, H.H. Antifungal and anticancer activities of a protein from the mushroom Cordyceps militaris. Korean J. Physiol. Pharmacol., 2009, 13(1), 49-54.
[86]
Wong, J.H.; Ng, T.B.; Wang, H.; Sze, S.C.; Zhang, K.Y.; Li, Q.; Lu, X. Cordymin, an antifungal peptide from the medicinal fungus Cordyceps militaris. Phytomedicine, 2011, 18(5), 387-392.
[87]
Qi, W.; Zhang, Y.; Yan, Y.B.; Lei, W.; Wu, Z.X.; Liu, N.; Liu, S.; Shi, L.; Fan, Y. The protective effect of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, on diabetic osteopenia in alloxan-induced diabetic rats. Evid. Based Complement. Alternat. Med., 2013, 2013, 985636.
[88]
Qian, G.M.; Pan, G.F.; Guo, J.Y. Anti-inflammatory and antinociceptive effects of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis. Nat. Prod. Res., 2012, 26(24), 2358-2362.
[89]
Wang, J.; Liu, Y.M.; Cao, W.; Yao, K.W.; Liu, Z.Q.; Guo, J.Y. Anti-inflammation and antioxidant effect of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Metab. Brain Dis., 2012, 27(2), 159-165.
[90]
Wang, H.; Ng, T.B. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides, 2006, 27(1), 27-30.
[91]
Suzuki, T.; Umehara, K.; Tashiro, A.; Kobayashi, Y.; Dohra, H.; Hirai, H.; Kawagishi, H. An antifungal protein from the culinary-medicinal beech mushroom, Hypsizygus marmoreus (Peck) Bigel. (Agaricomycetideae). Int. J. Med. Mushrooms, 2011, 13(1), 27-31.
[92]
Lam, S.K.; Ng, T.B. Hypsin, a novel thermostable ribosome-inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochem. Biophys. Res. Commun., 2001, 285(4), 1071-1075.
[93]
Wong, J.H.; Wang, H.X.; Ng, T.B. Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus. Appl. Microbiol. Biotechnol., 2008, 81(4), 669-674.
[94]
Pan, W.L.; Wong, J.H.; Fang, E.F.; Chan, Y.S.; Ye, X.J.; Ng, T.B. Differential inhibitory potencies and mechanisms of the type I ribosome inactivating protein marmorin on estrogen receptor (ER)-positive and ER-negative breast cancer cells. Biochim. Biophys. Acta, 2013, 1833(5), 987-996.
[95]
Ngai, P.H.; Ng, T.B. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci., 2003, 73(26), 3363-3374.
[96]
Lam, S.K.; Ng, T.B. First simultaneous isolation of a ribosome inactivating protein and an antifungal protein from a mushroom (Lyophyllum shimeji) together with evidence for synergism of their antifungal effects. Arch. Biochem. Biophys., 2001, 393(2), 271-280.
[97]
Wang, H.; Ng, T.B. Eryngin, a novel antifungal peptide from fruiting bodies of the edible mushroom Pleurotus eryngii. Peptides, 2004, 25(1), 1-5.
[98]
Chu, K.T.; Xia, L.; Ng, T.B. Pleurostrin, an antifungal peptide from the oyster mushroom. Peptides, 2005, 26(11), 2098-2103.
[99]
Guo, Y.; Wang, H.; Ng, T.B. Isolation of trichogin, an antifungal protein from fresh fruiting bodies of the edible mushroom Tricholoma giganteum. Peptides, 2005, 26(4), 575-580.
[100]
Longhi, C.; Santos, J.P.; Morey, A.T.; Marcato, P.D.; Duran, N.; Pinge-Filho, P.; Nakazato, G.; Yamada-Ogatta, S.F.; Yamauchi, L.M. Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans. Med. Mycol., 2016, 54(4), 428-432.
[101]
Aerts, A.M.; Bammens, L.; Govaert, G.; Carmona-Gutierrez, D.; Madeo, F.; Cammue, B.P.; Thevissen, K. The antifungal plant defensin HsAFP1 from Heuchera sanguinea induces apoptosis in Candida albicans. Front. Microbiol., 2011, 2, 47.
[102]
Aerts, A.M.; Carmona-Gutierrez, D.; Lefevre, S.; Govaert, G.; Francois, I.E.; Madeo, F.; Santos, R.; Cammue, B.P.; Thevissen, K. The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans. FEBS Lett., 2009, 583(15), 2513-2516.
[103]
Aerts, A.M.; Francois, I.E.; Meert, E.M.; Li, Q.T.; Cammue, B.P.; Thevissen, K. The antifungal activity of RsAFP2, a plant defensin from Raphanus sativus, involves the induction of reactive oxygen species in Candida albicans. J. Mol. Microbiol. Biotechnol., 2007, 13(4), 243-247.
[104]
De Cremer, K.; Staes, I.; Delattin, N.; Cammue, B.P.; Thevissen, K.; De Brucker, K. Combinatorial drug approaches to tackle Candida albicans biofilms. Expert Rev. Anti Infect. Ther., 2015, 13(8), 973-984.
[105]
Tavares, P.M.; Thevissen, K.; Cammue, B.P.; Francois, I.E.; Barreto-Bergter, E.; Taborda, C.P.; Marques, A.F.; Rodrigues, M.L.; Nimrichter, L. In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis. Antimicrob. Agents Chemother., 2008, 52(12), 4522-4525.
[106]
Thevissen, K.; Warnecke, D.C.; Francois, I.E.; Leipelt, M.; Heinz, E.; Ott, C.; Zahringer, U.; Thomma, B.P.; Ferket, K.K.; Cammue, B.P. Defensins from insects and plants interact with fungal glucosylceramides. J. Biol. Chem., 2004, 279(6), 3900-3905.
[107]
Thevissen, K.; de Mello Tavares, P.; Xu, D.; Blankenship, J.; Vandenbosch, D.; Idkowiak-Baldys, J.; Govaert, G.; Bink, A.; Rozental, S.; de Groot, P.W.; Davis, T.R.; Kumamoto, C.A.; Vargas, G.; Nimrichter, L.; Coenye, T.; Mitchell, A.; Roemer, T.; Hannun, Y.A.; Cammue, B.P. The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans. Mol. Microbiol., 2012, 84(1), 166-180.
[108]
Lin, P.; Xia, L.; Wong, J.H.; Ng, T.B.; Ye, X.; Wang, S.; Shi, X. Lipid transfer proteins from Brassica campestris and mung bean surpass mung bean chitinase in exploitability. J. Pept. Sci., 2007, 13(10), 642-648.
[109]
Chan, Y.S.; Ng, T.B. Northeast red beans produce a thermostable and pH-stable defensin-like peptide with potent antifungal activity. Cell Biochem. Biophys., 2013, 66(3), 637-648.
[110]
Chan, Y.S.; Wong, J.H.; Fang, E.F.; Pan, W.L.; Ng, T.B. An antifungal peptide from Phaseolus vulgaris cv. brown kidney bean. Acta Biochim. Biophys. Sin. (Shanghai), 2012, 44(4), 307-315.
[111]
Sha, O.; Niu, J.; Ng, T.B.; Cho, E.Y.; Fu, X.; Jiang, W. Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: A mini review. Cancer Chemother. Pharmacol., 2013, 71(6), 1387-1393.
[112]
Ouyang, D.Y.; Chan, H.; Wang, Y.Y.; Huang, H.; Tam, S.C.; Zheng, Y.T. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin. Biochem. Biophys. Res. Commun., 2006, 339(1), 25-29.
[113]
Kaur, I.; Gupta, R.C.; Puri, M. Ribosome inactivating proteins from plants inhibiting viruses. Virol. Sin., 2011, 26(6), 357-365.
[114]
Kahn, J.O.; Gorelick, K.J.; Gatti, G.; Arri, C.J.; Lifson, J.D.; Gambertoglio, J.G.; Bostrom, A.; Williams, R. Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex. Antimicrob. Agents Chemother., 1994, 38(2), 260-267.
[115]
Garcia, P.A.; Bredesen, D.E.; Vinters, H.V.; Graefin von Einsiedel, R.; Williams, R.L.; Kahn, J.O.; Byers, V.S.; Levin, A.S.; Waites, L.A.; Messing, R.O. Neurological reactions in HIV-infected patients treated with trichosanthin. Neuropathol. Appl. Neurobiol., 1993, 19(5), 402-405.
[116]
Byers, V.S.; Levin, A.S.; Waites, L.A.; Starrett, B.A.; Mayer, R.A.; Clegg, J.A.; Price, M.R.; Robins, R.A.; Delaney, M.; Baldwin, R.W. A phase I/II study of trichosanthin treatment of HIV disease. AIDS, 1990, 4(12), 1189-1196.
[117]
Byers, V.S.; Levin, A.S.; Malvino, A.; Waites, L.; Robins, R.A.; Baldwin, R.W. A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents. AIDS Res. Hum. Retroviruses, 1994, 10(4), 413-420.
[118]
Lee-Huang, S.; Huang, P.L.; Bourinbaiar, A.S.; Chen, H.C.; Kung, H.F. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc. Natl. Acad. Sci. USA, 1995, 92(19), 8818-8822.
[119]
Li, X.C.; Jacob, M.R.; Khan, S.I.; Ashfaq, M.K.; Babu, K.S.; Agarwal, A.K.; Elsohly, H.N.; Manly, S.P.; Clark, A.M. Potent in vitro antifungal activities of naturally occurring acetylenic acids. Antimicrob. Agents Chemother., 2008, 52(7), 2442-2448.
[120]
Xu, T.; Tripathi, S.K.; Feng, Q.; Lorenz, M.C.; Wright, M.A.; Jacob, M.R.; Mask, M.M.; Baerson, S.R.; Li, X.C.; Clark, A.M.; Agarwal, A.K. A potent plant-derived antifungal acetylenic acid mediates its activity by interfering with fatty acid homeostasis. Antimicrob. Agents Chemother., 2012, 56(6), 2894-2907.
[121]
de Castro, A.P.; Franco, O.L. Modifying natural antimicrobial peptides to generate bioinspired antibiotics and devices. Future Med. Chem., 2015, 7(4), 413-415.
[122]
Dias Rde, O.; Machado Ldos, S.; Migliolo, L.; Franco, O.L. Insights into animal and plant lectins with antimicrobial activities. Molecules, 2015, 20(1), 519-541.
[123]
Lima, S.M.; de Padua, G.M.; Sousa, M.G.; Freire Mde, S.; Franco, O.L.; Rezende, T.M. Antimicrobial peptide-based treatment for endodontic infections--biotechnological innovation in endodontics. Biotechnol. Adv., 2015, 33(1), 203-213.
Download PDF Flyer